A compound that strongly inhibits botulinum neurotoxin has been identified by researchers.

The compound – called nitrophenyl psoralen (NPP) – could be used as a treatment to reduce paralysis induced by botulism.

There is no FDA-approved antidote for botulinum neurotoxin (BoNT). Psoralen derived drugs are approved by the U.S. Food
Continue Reading Researchers find possible antidote for paralysis in botulism cases